Generic Name and Formulations:
Glatiramer acetate 20mg/mL, 40mg/mL; soln for SC inj; contains mannitol; preservative-free.
Indications for COPAXONE:
Relapsing forms of multiple sclerosis.
Supervise 1st dose. Give only by SC inj into arms, abdomen, hips, thighs. Rotate inj sites. ≥18yrs: 20mg once daily or 40mg three times weekly (at least 48hrs apart). The 20mg/mL and 40mg/mL injections are not interchangeable.
<18yrs: not established.
Risk of post-injection reactions. May potentially interfere with immune functions. Pregnancy (Cat.B). Nursing mothers.
Inj site reactions, vasodilatation, rash, dyspnea, chest pain, asthenia, infection, pain, nausea, anxiety; rare: lipoatrophy, skin necrosis.
Single-use prefilled syringes 20mg/mL—30; 40mg/mL—12
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis